W Pirker, S Happe. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antiparkinson Agents/adverse effectsAntiparkinson Agents/therapeutic useDisorders of Excessive Somnolence/chemically inducedDopamine Agonists/adverse effectsDopamine Agonists/therapeutic useHumansIndoles/adverse effectsIndoles/therapeutic useMaleMiddle AgedParkinson Disease/drug therapy
Substances: See more » Antiparkinson AgentsDopamine AgonistsIndolesropinirole
Year: 2000 PMID: 10950264 DOI: 10.1016/S0140-6736(05)73981-7
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321